Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapy

[1]  P. Lange,et al.  Recent reflections on tumor markers , 1984, World Journal of Urology.

[2]  T. Ahlering,et al.  Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. , 1994, Urology.

[3]  R. Flanigan,et al.  Miscellaneous aspects of bladder and testicular oncology , 1993 .

[4]  E. Klein,et al.  Tumor markers in testis cancer. , 1993, The Urologic clinics of North America.

[5]  D. Dearnaley,et al.  Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. , 1993, British journal of urology.

[6]  L. Einhorn,et al.  Surgical salvage of chemorefractory germ cell tumors. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. Mann,et al.  Der falsch-positive' Tumormarker beim malignen Hodentumor : Hodentumor , 1993 .

[8]  R. Motzer,et al.  Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers , 1992, Cancer.

[9]  T. Splinter,et al.  Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma. , 1991, The Journal of urology.

[10]  E. Dmitrovsky,et al.  The role of ifosfamide plus cisplatin‐based chemotherapy as salvage therapy for patients with refractory germ cell tumors , 1990, Cancer.

[11]  D. Sleijfer,et al.  Late recurrence of mature teratoma in nonseminomatous testicular tumors after PVB chemotherapy and surgery. , 1989, Urology.

[12]  D. Sleijfer,et al.  Sexual function after surgery and combination chemotherapy in men with disseminated nonseminomatous testicular cancer , 1988, Journal of surgical oncology.

[13]  F. Freiha,et al.  The extent of surgery after chemotherapy for advanced germ cell tumors. , 1984, The Journal of urology.

[14]  R. Oliver.  Testis cancer. , 1997, Current opinion in oncology.

[15]  R. Hartung,et al.  Grenzen der tumormarkerorientierten Verlaufskontrolle beim chemotherapierten, metastasierenden, nicht-seminomatösen Hodentumor , 1983 .